Allurion Technologies, Inc. (ALUR NYSE) stock market data APIs
$1.5063
0(0%)
as of December 17, 2025
Try our APIs with
free plan!
Allurion Technologies, Inc. Financial Data Overview
Price chart is built with
Anychart
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Prev. Close
1.5063
Open
1.5048
High
1.5471
Low
1.5025
52 wk Range
1.02-13.75
Market Cap
18 385 K
Shares Outstanding
12 257 K
Revenue
17 208 K
EPS
-1.1836
Beta
-0.488
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Allurion Technologies, Inc. data using free add-ons & libraries
Get Allurion Technologies, Inc. Fundamental Data
Allurion Technologies, Inc. Fundamental data includes:
- Net Revenue: 17 208 K
- EBITDA: -34 941 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -2.45
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Allurion Technologies, Inc. News
New
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
For Immediate Release Chicago, IL – November 18, 2025 – Today, Zacks Equity Research discusses Boston Scientific BSX, Insulet PODD, BioLife Solutions BLFS and Allurion Technologies ALUR. Industr...
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical - Products industry is grappling with a difficult operating landscape marked by tariff-driven cost inflation, persistent supply-chain delays, and uneven macroeconomic conditions tha...
Allurion signals sequential revenue growth into 2026 as FDA review nears completion
Earnings Call Insights: Allurion Technologies Inc. (ALUR) Q3 2025 MANAGEMENT VIEW * Shantanu Gaur, Co-Founder, CEO, President, Principal Financial & Accounting Officer and Director, highlighted re...
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Confer...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
